Title: Growth and forecast of molecular diagnostics in Cancer and Prenatal Diagnostics
1Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
Explore all reports for Diagnostics market _at_
http//www.lifescienceindustryresearch.com/catego
ry/diagnostics .
2Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
- Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies covers market research, relevant
disease background, and a number of rising
technologies available to physicians and
clinicians in the cancer and prenatal space. This
report focuses on market background of the areas
that are covered, including lung, breast, thyroid
and blood cancers (specifically leukemia and
lymphoma), as well as pre-conception genetic
information and prenatal diagnostics. - Included in this Report
- Cancer diagnostics companies interviewed include
GeneCentric, Veracyte, Adaptive Biotechnologies
3Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
- Genetic and prenatal diagnostics research
companies including GenePeeks and Verinata Health - Comprehensive coverage of survey results (n123)
from the various companies and researchers
working in molecular diagnostics. - A company directory which was created for this
report. This includes several seasoned and
emerging companies, their areas of focus, and the
status of their technologies - Executive Summary
- Molecular Diagnostics An Insight to Rising
Markets and
4Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
- Trends in Cancer and Prenatal Technologies covers
market research, relevant disease background, and
a number of rising technologies available to
physicians and clinicians. - This report has been divided into five parts. The
first part of this report will focus on market
growth and molecular diagnostic interest (Chapter
2). This chapter will discuss a brief overview of
the growth of molecular diagnostics in several
areas of cancer as well as prenatal diagnostics.
These areas will be further discussed in later
sections.
5Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
Part II focuses on cancer diagnostics, covering
lung, breast, thyroid and blood cancers. These
sections will include background information on
all four types of cancers including risk,
incidence, symptoms, early detection, and even
targets under investigation. Information on a
variety of companies working in the related
cancer spaces and exclusive interviews with CEOs,
Presidents, and Founders are also included. The
companies that are featured include GeneCentric,
which has two platforms available for breast and
lung cancer Veracyte, which has a platform for
screening thyroid nodules found indeterminate by
flow
6Molecular Diagnostics An Insight to Rising
Markets and Trends in Cancer and Prenatal
Technologies
cytometry and Adaptive Biotechnologies, which
has a platform specifically for monitoring
minimal residual disease (MRD) in blood cancers.
Although these companies focus on different
cancer-types, it is interesting to see the
approach they are taking to meet market needs and
tackle various diseases.
7About lifescienceindustryresearch.com
lifescienceindustryresearch.com is your single
source for all market research needs. Our
database includes 250,000 syndicated market
research reports from 100 leading global
publishers covering in-depth analysis of over
5000 micro markets. With comprehensive
information about the publishers and their report
methodology, data sources, etc. we help you in
your purchase decision by mapping your
information needs with the most relevant
available reports in our library.
Connect with us sales_at_lifescienceindustryresearc
h.com 1 888 391 5441 Contact http//www.lifes
cienceindustryresearch.com for further
information.
Contact sales_at_reportsandreports.com for further
information.